delivered the opinion of the, Court.
The Freedom of Information Act, 5 U. S. C. § 552, empowers federal courts to order an “agency”, to produce “agency records improperly withheld” from an individual requesting access. § 552 (a)(4)(B). We hold here that written data generated, owned, and possessed by a privately controlled organization receiving federal study grants aré not “agency records” within the meaning of the Act when copies of those data have not been obtained by a federal agency subject to the FOIA. Federal participation in the generation of the data by means of a grant from the Department of Health, Education, and Welfare. (HEW) does not make the private organization a federal “agency” within the terms of the Act. Nor does this federal funding in combination with a federal right of access render the data “agency records” of HEW, which is a federal “agency” under the terms of the Act.
I
In 1959, a group of private physicians and scientists specializing in the treatment of diabetes formed the University Group Diabetes Program (UGDP). The UGDP conducted a long-term study of the effectiveness of five diabetes treatment regimens. Two of these treatment regimens involved diet control in combination with the administration of either tolbutamide, or phenformin hydrochloride, both “oral hypoglycemic” drugs. The UGDP’s participating physicians were located at 12 clinics nationwide and the study was coordinated at the Coordinating Center of the University of Maryland.
The Committee on the Care of the Diabetic (CCD), a national association of physicians involved in the treatment of diabetes mellitus patients, have been among those critical of the TJGDP study. CCD requested the TJGDP to grant it access to the raw data in order to facilitate its review of the TJGDP findings, but TJGDP has declined to comply with that request. CCD therefore sought to obtain the information under the Freedom of Information Act. The essential facts are not in dispute, and we hereafter set forth those relevant to our decision.
The TJGDP study has been solely funded by federal grants in the neighborhood of $15 million between 1961 and 1978. These grants were awarded TJGDP by the National Institute of Arthritis, Metabolism, and Digestive Diseases (NIAMDD), a federal agency,
1
pursuant to the Public Health Service Act, 42 U. S. C. § 241 (c). NIAMDD has not only awarded the federal grants to TJGDP, but has exercised a certain amount
The grantee has also retained control of its records: the patient records and raw data generated by UGDP have at all times remained in the possession of that entity, and neither the NIAMDD grants nor related regulations shift ownership of such data to the Federal Government. NIAMDD does, however, have a right of access to the data in order to insure compliance with the grant. 45 CFR § 74.24 (a) (1979). And the Government may obtain permanent custody of the documents upon request. § 74.21 (c). But NIAMDD has not exercised its right either to review or to obtain permanent custody of the data.
Although no employees of the NIAMDD have reviewed the UGDP records, the Institute did contract in 1972 with another private grantee, the Biometric Society, for an assessment of the validity of the UGDP study. The Biometric Society was given direct access to the UGDP raw data by the terms of its contract with NIAMDD. The contract with the Biometric Society, however, did not require the Society to seek access to the UGDP raw data, nor did it require that any data actually reviewed be transmitted to the NIAMDD. While the Society did review some UGDP data, it did not submit any raw data reviewed by it to the NIAMDD. The Society
An additional connection between the Federal Government and the UGDP study has occurred through the activities of the Food and Drug Administration. After the FDA was apprised of the UGDP results, the agency issued a statement recommending that physicians use tolbutamide in the treatment of diabetes only in limited circumstances. After the UGDP reported finding a similarly higher incidence of cardiovascular disease with the administration of phenformin, the FDA proposed changes in the labeling of these oral hypoglycemic drugs to warn patients of cardiovascular hazards. FDA Drug Bulletin (June 23, 1971). The FDA deferred further action on this labeling proposal, however, until the Biometric Society completed its review of the UGDP study. 3
After the Biometric study was issued, FDA renewed its proposal to require a label warning that oral hypoglyeemics should be used only in cases of adult-onset, stable diabetes that could not be treated adequately by a combination of diet and insulin. The FDA clearly relied on the UGDP study in renewing this position. 40 Fed. Reg. 28587, 28591 (1975). At the time the proposal was published, the FDA invited public comment. In response to criticism of the UGDP study and the Biometric Society’s audit, the FDA conducted its own audit of the UGDP study pursuant to a delegation of NIAMDD’s authority to audit grantee records. In conducting this audit, the FDA examined and copied a small sample of the UGDP raw data. This audit report has been made available for public inspection. 43 Fed. Reg. 52733 (1978).
Although this labeling proposal has not yet become final, other FDA regulatory action has been taken. On July 25,
The Court of Appeals affirmed on the same rationale.
Forsham
v.
Califano,
190 U. S. App. D. C. 231,
II
As we hold in the companion case of Kissinger v. Reporters Committee for Freedom of the Press, ante, p. 136, it must be established that an “agency” has “improperly withheld agency records” for an individual to obtain access to documents through an FOIA action. We hold here that HEW need not produce the requested data because they are not “agency records” within the meaning of the FOIA. In so holding, we reject three separate but related claims of petitioners: (1) the data they seek are “agency records” because they were at least “records” of UGDP, and UGDP in turn received its funds from a federal agency and was subject to some supervision by the agency in its use of those funds; (2) the data they seek are “agency records” because HEW, concededly a federal agency, had sufficient authority under its grant agreement to have obtained the data had it chosen to do so; and (3) the data are “agency records” because they formed the basis for the published reports of UGDP, which in turn were relied upon by the FDA in the actions described above. 7
A
We first examine petitioners’ claim that the data were at least records of UGDP, and that the federal funding and supervision of UGDP alone provides the close connection necessary to render
its
records “agency records” as that term is used in the Freedom of Information Act. Congress did not define “agency record” under the FOIA, but it did define “agency.” The definition of “agency” reveals a great deal about congressional intent as to the availability of records
Under 5 U. S. C. § 552 (e) an “agency” is defined as
“any executive department, military department, Government corporation, Government controlled corporation, or other establishment in the executive branch of the Government ... , or any independent regulatory agency.”
The legislative history indicates unequivocally that private organizations receiving federal financial assistance grants are not within the definition of “agency.” In their Report, the conferees stated that they did “not intend to include corporations which receive appropriated funds but are neither chartered by the Federal Government nor controlled by it, such as the Corporation for Public Broadcasting.” H. Conf. Rep. No. 93-1380, pp. 14-15 (1974), reprinted in Freedom of Information Act and Amendments of 1974 Source Book 231-232 (Jt. Comm. Print 1975). Through operation of this exclusion, Congress chose not to confer any direct public rights of access to such federally funded project information. 10
Congress could have provided that the records generated by a federally funded grantee were federal property even though the grantee has not been adopted as a federal entity. But Congress has not done so, reflecting the same regard for the autonomy of the grantee’s records as for the grantee itself. Congress expressly requires an agency to use “procurement contracts” when the “principal purpose of the instrument is the acquisition ... of property or services for the direct benefit or use of the Federal Government. . . .” Federal Grant and Cooperative Agreement Act of 1977, § 4, 92 Stat. 4, 41 U. S. C. § 503 (1976 ed., Supp. II).. In contrast, “grant agreements” must be used when money is given to a recipient “in order to accomplish a public purpose of support or stimulation authorized by Federal statute, rather than acquisition ... of property or services. ...” § 5, 41 U. S. C. § 504 (1976 ed., Supp. II). As in this case, where a grant was used,
The fact that Congress has chosen not to make a federal grantee an “agency” or to vest ownership of the records in the Government does not resolve with mathematical precision the question of whether the granting agency’s funding and supervisory activities nevertheless make the grantee’s records “agency records.” Records of a nonagency certainly could become records of an agency as well. But if Congress found that federal funding and supervision did not justify direct access to the grantee’s records, as it clearly did, we fail to see why we should nevertheless conclude that those identical activities were intended to permit indirect access through an expansive definition of “agency records.”
13
Such a con-
These considerations do not finally conclude the inquiry, for conceivably other facts might indicate that the documents could be “agency records” even though generated by a private grantee. The definition of “agency” and congressional policy towards grantee records indicate, however, that Congress did not intend that grant supervision short of Government control serve as. a sufficient basis to make the private records “agency records” under the Act, and reveal a congressional determination to keep federal grantees free from the direct obligations imposed by the TOLA. In ascertaining the intended expanse of the term “agency records” then, we must, of course, construe the Act with regard both for the congressional purpose of increasing public access to governmental records and for this equally explicit purpose of retaining grantee autonomy.
B
Petitioners seek to prevail on their second and third theories, even though their first be rejected, by invoking a broad definition of “agency records,” so as to include all documents created by a private grantee to which the Government has access, and which the Government has used.' We do not believe that this broad definition of “agency records,” a term undefined in the FOIA, is supported by either the language of that Act or its legislative history. We instead agree with the opinions of the courts below that Congress contemplated that an agency must first either create or obtain a record as a prerequisite to its becoming an “agency record” within the meaning of the FOIA. While it would be stretching the ordinary meaning of the words to call the data in question here “agency records,” we need not rest our conclusions solely on the “plain language” rule of statutory construction. The use of the term “record” by Congress in two other Acts, and the structure
Although Congress has supplied no definition of agency records in the FOIA, it has formulated a definition in other Acts. The Records Disposal Act, in effect at the time Congress enacted, the Freedom of Information Act, provides the following threshold requirement for agency records:
“ 'records’ includes all books, papers, maps, photographs, machine readable materials, or other documentary materials, regardless of physical form or characteristics, made or received by an agency of the United States Government under Federal law or in connection with the transaction of public business. . . 44 U. S. C. § 3301. 14
(Emphasis added.)
The Attorney General’s Memorandum on the Public Information Section of the Administrative Procedure Act 23-24 (1967), S. Doc. No. 93-82, pp. 222-223 (1974), concludes that Congress intended this aspect of the Records Act definition to apply to the Freedom of Information Act.
The same standard emerges in the Presidential Records Act of 1978. The term “presidential records” is defined as “documentary materials ...
created or received
by the President. . . .” 44 U. S. C. 1 2201 (2) (1976 ed., Supp. II). (Emphasis added.) While these definitions are not disposi-
The only direct reference to a definition of records in the legislative history, of which we are aware, occurred during the Senate hearings leading to the enactment of FOIA. A representative of the Interstate Commerce Commission commented that “[s]ince the word ‘records’ ... is not defined, we assume that it includes all papers which an agency preserves in the performance of its functions.” Administrative Procedure Act: Hearings on S. 1160 et al. before the Subcommittee on Administrative Practice and Procedure of the Senate Committee on the Judiciary, 89th Cong., 1st Sess., 244 (1965). 15 The legislative history of the FOIA abounds with other references to records acquired by an agency. For example, the legislative Reports clarify that confidential information “submitted ... to a Government . . . agency,” “obtained by the Government,” or “given to an agency” otherwise subject to disclosure, was made exempt. S. Rep. No. 813, 89th Cong., 1st Sess., 9 (1965), reprinted in Freedom of Information Act Source Book, S. Doc. No. 93-82, p. 44 (Comm. Print 1974); H. R. Rep. No. 1497, 89th Cong., 2d Sess. (1966), reprinted in Source Book, at 31.
Section 552 (b)(4) provides the strongest structural support for this construction. This section exempts trade secrets and commercial or financial information “obtained from a person.” This exemption was designed to protect confidential information “submitted” by a borrower to a lending agency or “obtained by the Government” through questionnaires or other inquiries, where such information “would customarily not be released to the public by the person from whom it was
The same focus emerges in a congressional amendment to the Securities Exchange Act of 1934. That Act had provided its own standards for public access to documents generated by the Act. Congress amended the Act to provide:
“For purposes of [the FOIA] the term 'records’ includes , all applications, statements, reports, contracts, correspondence, notices, and other documents filed with or otherwise obtained by the Commission pursuant to this chapter or otherwise.” (Emphasis added.) 15 U. S. C. § 78x.
We think that the weight this construction lends to our conclusion is overborne neither by an agency’s potential access to the grantee’s information nor by its reliance on that information in carrying out the various duties entrusted to it by Congress. The Freedom of Information Act deals with “agency records,” not information in the abstract. Petitioners place great reliance on the fact that HEW has a right of access to the data, and a right if it so chooses to obtain permanent custody of the UGDP records. 45 CFR §§ 74.24.
We think the foregoing reasons dispose of all petitioners’ arguments. We therefore conclude that the data petitioners seek are not “agency records” within the meaning of the FOIA. UGDP is not a “federal agency” as that term is defined in the FOIA, and the data petitioners seek have not been created or obtained by a federal agency. Having failed to establish
Affirmed.
I agree with the Court that “[rjecords of a nonagency certainly could become records of an agency as well.” Ante, at 181. But the Court does not explain why such a conversion does not occur in this case. 1 Because I believe we should articulate standards under which to analyze such cases and because I believe that under a proper test UGDP’s data should be treated as “agency records,” I dissent.
I
The Court argues at length that UGDP is not an agency. But whether or not UGDP is an “agency” is simply not at issue in this case. Rather, the only question is whether data generated in the course of this UGDP study are “agency records.”
The Court concedes, of course, that the statute itself does not define “agency records.”
2
Therefore, our task is to con
Where the nexus between the agency and the requested information is close, and where the importance of the information to public understanding of the decisions or the operation
Admittedly, this test does not establish a bright line, but the evaluation of a calculus of relevant factors is nothing new to the law. 5 The first such factor is the importance of the record to an understanding of Government activities. If, for instance, the significance of the record is limited to understanding the workings of the nonagency, the public has no FOIA-protected interest in access. The weight to be given this factor can be tested by examining the role accorded the material in agency writings and the extent to which the agency reached its conclusions in reliance upon the particular source.
Mere materiality of information, standing alone, of course, is not enough.
6
POIA does not give the public any unrestricted right to examine all data relied on by an agency. Congress required that the information constitute an “agency record.” Thus, another necessary factor is'that there be a link between the agency and the record.
7
Nothing in FOIA or its history suggests, however, that the connection must amount to outright possession or creation. Instead, again drawing from the legislative purposes, I believe the link must be such that the agency has treated the record as if it were
II
On the facts of this case, I would conclude that UGDP’s raw data are records of HEW. Both HEW and the FDA have taken significant actions in complete reliance on the UGDP study. The FDA has directly endorsed the study’s conclusions and, in reliance thereon, sought mandatory labeling warnings on the drugs criticized by the UGDP. HEW cited the UGDP study as one of its basic sources when it suspended one of the drugs as an immediate hazard. The suggestion that these administrative actions relied solely on the published reports and not on the underlying raw data at issue here is unrealistic. The conclusions can be no stronger or weaker than the data on which they are based. One cannot even begin to evaluate an agency action without access to the raw data on which the conclusions were based, especially in a case such as this where the data are nonduplicable. The importance of the raw data in evaluating derivative conclusions was
This case is set against the background of an intense, often bitter, 9 battle being waged in the medical community over the validity of the UGDP study and the correct treatment regimen for diabetes. By endorsing the UGDP study the Federal Government has aligned itself on one side of the fight and has all but outlawed the regimen recommended by the other side. Petitioners in this case are medical scientists seeking to resolve questions that have been raised about the scientific and statistical methods underlying an agency’s conclusions. This seems to me to be an archetypical instance of the need for public dissemination of the information.
Even so, I doubt that the information could be held to be an “agency record” had the Government not been so deeply involved in its creation. Petitioners have argued that the National Institutes of Health, in effect, did create these records. The agency not only completely funded the project’s operation, but initiated the project and took responsibility for developing its research protocol as well. See
Forsham
v.
Califano,
190 U. S. App. D. C., at 251,
Ill
I emphasize that the standards I suggest do not mean opening to the public the files of all grantees or of all who submit information to the Government. In many cases grantees’ records should not be treated as agency records. But the Court’s approach must inevitably undermine FOIA’s great purpose of exposing Government to the people. It is unavoidable that as the work of federal agencies mushrooms both in quantity and complexity the agencies must look to outside organizations to assist in governmental tasks. Just as the explosion of federal agencies, which are not directly responsible to the electorate, worked to hide the workings of the Federal Government from voters before enactment of FOIA, S. Rep. No. 813, 89th Cong., 1st Sess., 3 (1965), the understandable tendency of agencies to rely on nongovernmental grantees to perform myriad projects distances the electorate from important information by one more step. If the records of such organizations, when drawn directly into the regulatory process, are immune from public inspection, then government by secrecy must surely return.
Notes
The NIAMDD is one of several Institutes of the National Institutes of Health (NIH). It is authorized by statute to conduct and fund research on diabetes and other diseases. 42 U. S. C. §§ 289a, 289c-1. The NIH are a component of the federal Public Health Service, which is itself a part of the Department of Health, Education, and Welfare. See Reorg. Plan No. 3 of 1966, 3 CFR 1023 (1966-1970 Comp.), note Mowing 42 U. S. C. §202, and Reorganization Order of April 1, 1968, 33 Fed. Reg. 5426.
Petitioners do contend that the federal supervision of the UGDP study was substantial and more extensive than that ordinarily exercised. They do not, however, maintain that there was day-to-day supervision. See infra, at 180, and n. 11.
Prior to the FDA’s decision to defer action, petitioners in this case sued the FDA to enjoin the proposed labeling, contesting the validity of the UGDP study. The First Circuit remanded the case to the FDA for exhaustion of administrative remedies.
Bradley
v.
Weinberger,
The order of the Commissioner discounts reliance on the TJGDP study. The order states that the AU was correct in concluding that from “an evidentiary standpoint” the “lack of availability of underlying data casts considerable doubt on the reliability of the TJGDP conclusions.” 44 Fed. Reg. 20969 (1979). The ALJ did permit reference to the TJGDP study as a basis for expert opinion. The Commissioner concluded that this use of the study was permissible since the data underlying expert opinions need not always be admitted to substantiate the opinions. Nearly 400 published articles were included in the record of the phenformin proceeding and none of the articles was accompanied by the raw data on which they were based. The Commissioner noted that the ALJ referenced the TJGDP study in only one paragraph of his eightr-page summary.
The Commissioner concluded that the agency.was not required to submit the TJGDP data since it had not relied upon that data, but only upon the actual study. 21 CFR § 12.85 (1979). Nevertheless, the Commissioner stated that he “reviewed the testimony of the Bureau of Drug’s expert witnesses and [found] that their reliance upon the TJGDP study was not substantial and cannot reasonably be characterized as pivotal to the opinions expressed by those witnesses.” 44 Fed. Reg. 20969 (1979).
The denial of . this FOIA request preceded the FDA’s audit of the UGDP data.
The court opinion also suggested that a document is an “agency record” if the federal agency has a duty to obtain the record. 190 U. S. App. D. C., at 239, and n. 18,
Petitioners maintain that the FDA has relied on all the raw data through reliance on the report and through reliance on information obtained pursuant to its audit of a sample of the data. The Court of Appeals found, however, that data reviewed by the FDA have been made available to petitioners.
Id.,
at 236,
In § 552 (a) (3) Congress did not use the term “agency records.” That section provides: “[E]ach agency, upon any request for records . . . shall make the records promptly available to any person.” Since the enforcement provision of the Act, §552 (a)(4)(B), refers only to “agency records” it is certain that the disclosure obligations imposed by §552 (a) (3) were only intended to extend to agency records. That limitation is implicit throughout the Act.
We use the term “grantee” or “private grantee” to describe private recipients of federal funds not subjected to sufficient Government control to render them federal agencies. We do not suggest, by use of this term, that an organization receiving federal grant funds could never be found to be a federal agency. See infra, at 180, and n. 11.
Numerous bills seeking to extend the FOIA to federal grantees have been introduced in each Congress since the 92d, but none has yet been reported .out of committee. See H. R. 11013, 92d Cong., 1st Sess. (1969); H. R. 1291, 93d Cong., 1st Sess. (1973); H. R. 1205, 94th Cong., 1st Sess. (1975); H. R. 3207, 95th Cong., 1st Sess. (1977); H. R. 1465, 96th Cong., 1st Sess. (1979).
Before characterizing an entity as “federal” for some purpose, this Court has required a threshold showing of substantial federal supervision of the private activities, and not just the exercise of regulatory authority necessary to assure compliance with the goals of the federal grant. See
United States
v.
Orleans,
The particular grant agreement in issue similarly confers on the NIAMDD a limited right of access to “records of the grantee.”
Nor could this distinction be explained by a hypothetical congressional preference for placing the burdens of production on the agency rather than the private grantee. Although under the petitioners’ construction of the Act the request would have to be made by the agency, the administrative burdens of searching and producing, or providing access, would necessarily accrue substantially to the party in possession, i. e., the private grantee.
The definition of “records” under the Records Disposal Act further requires that records made or received by the agency also be “preserved or appropriate for preservation by that agency ... as evidence of the organization, functions, policies, decisions, procedures, operations, or other activities of the Government or because of the informational value of data in them.” Government documents made or received by an agency that are not appropriate for preservation are referred to as “nonrecord materials.” 41 CFR § 101-11.401-3 (d) (1979). It has not been settled whether the FOIA definition of agency records extends to “nonrecord materials.” We need not reach that question since the documents sought by petitioners do not meet the threshold requirement that they be “made or received” by a federal agency.
It is interesting to note that the witness expressed concern that such an “all-expansive meaning” necessitated clear categorical exemptions.
We certainly do not indicate, however, that physical possession, or initial creation, is by itself always sufficient. See Kissinger, ante, at 157.
We need not categorize what agency conduct is necessary to support a finding that it has “obtained” documents, since an unexercised right of access clearly does not satisfy this requirement. Government access to documents clearly could not be the central component of the definition of agency records contemplated by Congress since the Federal Government has access to near astronomical numbers of private documents. A mere sampling of access statutes includes: Internal Revenue Code of 1954, § 7602, 26 U. S. C. § 7602 (taxpayers or potential taxpayers); 15 U. S. C. §§ 78q, 78u (persons subject to the Securities Exchange Act of 1934) ; 29 U. S. C. § 657 (each employer subject to the Occupational Safety and Health Act of 1970).
Even if the Court were to accept petitioners’ argument that only contractual access should give rise to “agency record” status, a limitation which does not appear readily supportable, the class of documents subject to FOIA disclosure would still be staggering. The record in this case indicates that NIAMDD alone has some 18,000 research grants outstanding.
The Court suggests that if a federal grant created a partnership or joint venture between the agency and the grantee, the grantee might become an agency and, thus, its records might become agency records. Ante, at 180. Likewise, the Court might reach a different result where the agency has chosen to buy data through a procurement contract instead of a grant. Ibid. But neither of these is an instance involving records of a nonagency. In the first the grantee becomes an agency, and in the second the records do not belong to the nonagency.
Therefore, the Court surely overstates the fact in saying that Congress “clearly” found that federal funding and supervision are not relevant to whether direct access to grantee’s records is justified,
ante,
at 181, and the Court does not explain why Congress’ silence “reflect[s] the same regard for the autonomy of the grantee’s records as for the grantee itself,”
ante,
at 180. Moreover, nothing whatever is cited in the legislative history to support the Court’s claim that the “purpose of retaining grantee autonomy”
I find the Court’s references to other statutes unenlightening. The Records Disposal Act and Presidential Records Act of 1978 are properly limited to records created or received because the agencies or the Executive cannot physically dispose of what they do not possess. These Acts are aimed at monitoring the physical destruction of agency documents and settling claims of ownership of Presidential documents. The agencies and the Executive cannot destroy or take for private use what they have never possessed.
As for the “structural” argument drawn from 5 U. S. C. § 552 (b) (4), I cannot imagine that trade secrets or commercial information not submitted to the Government would have been created or used for governmental purposes or with governmental funds. In short, the Government would have no claim of any kind on the information if it had not been submitted.
FOIA was enacted because agencies had turned the predecessor statute on its head, transforming a public information statute into a secrecy statute. H. R. Rep. No. 1497, 89th Cong., 2d Sess. (1966), reprinted in Freedom of Information Act Source Book, S. Doc. No. 93-82, pp. 22, 25-27 (Comm. Print 1974).
The Court offers no manageable standards of any kind. No guidance is given to the decisionmaker as to how to determine at what point a relationship' between an agency and another organization ripens into a "joint venture.” And, of course, we are given no key to guide the determination of what nonageney records “become records of an agency as well.” Ante, at 181.
The Court, by insisting on analyzing petitioners’ contentions separately, never addresses the full, combined force of the arguments. It is only in combination that the various factors alluded to by petitioners tell the full story of governmental reliance on and involvement with the data and, thus, the importance to the success of Congress’ FOIA scheme of disclosing this information.
See Note, The Definition of “Agency Records” Under the Freedom of Information Act, 31 Stan. L. Rev. 1093, 1106-1114 (1979).
Certainly the agency cannot control the legal consequences simply by the label it attaches to a relationship.
One former UGDP investigator has challenged the scientific honesty of the research coordinator, who is also the current custodian of the raw data.
Because the case comes to us on affirmance of the grant of respondents’ motion for summary judgment, we must accept petitioners’ version of any disputed facts. Thus, for instance, we are not free to de-emphasize the extent of federal supervision of the UGDP study alleged by petitioners.
